[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]
Identifieur interne : 000147 ( Main/Exploration ); précédent : 000146; suivant : 000148[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]
Auteurs : J-M Cosset [France] ; É Deutsch [France] ; L. Bazire [France] ; J-J Mazeron [France] ; C. Chargari [France]Source :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1769-6658 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (MeSH), Dosimétrie en radiothérapie (MeSH), Déplétion lymphocytaire (MeSH), Humains (MeSH), Immunosuppression thérapeutique (MeSH), Infections à coronavirus (complications), Infections à coronavirus (radiothérapie), Maladies pulmonaires (radiothérapie), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (radiothérapie), Poumon (effets des radiations), Sujet immunodéprimé (MeSH).
- MESH :
- effets des radiations : Poumon.
- radiothérapie : Infections à coronavirus, Maladies pulmonaires, Pneumopathie virale.
- complications : Betacoronavirus, Dosimétrie en radiothérapie, Déplétion lymphocytaire, Humains, Immunosuppression thérapeutique, Infections à coronavirus, Pandémies, Pneumopathie virale, Sujet immunodéprimé.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), Coronavirus Infections (complications), Coronavirus Infections (radiotherapy), Cytokine Release Syndrome (etiology), Cytokine Release Syndrome (radiotherapy), Humans (MeSH), Immunocompromised Host (MeSH), Immunosuppression (MeSH), Lung (radiation effects), Lung Diseases (radiotherapy), Lymphocyte Depletion (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (radiotherapy), Radiotherapy Dosage (MeSH).
- MESH :
- complications : Coronavirus Infections, Pneumonia, Viral.
- etiology : Cytokine Release Syndrome.
- radiation effects : Lung.
- radiotherapy : Coronavirus Infections, Cytokine Release Syndrome, Lung Diseases, Pneumonia, Viral.
- Betacoronavirus, Humans, Immunocompromised Host, Immunosuppression, Lymphocyte Depletion, Pandemics, Radiotherapy Dosage.
DOI: 10.1016/j.canrad.2020.04.003
PubMed: 32389579
PubMed Central: PMC7252150
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]</title><author><name sortKey="Cosset, J M" sort="Cosset, J M" uniqKey="Cosset J" first="J-M" last="Cosset">J-M Cosset</name><affiliation wicri:level="3"><nlm:affiliation>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">La Garenne-Colombes</settlement></placeName></affiliation></author><author><name sortKey="Deutsch, E" sort="Deutsch, E" uniqKey="Deutsch E" first="É" last="Deutsch">É Deutsch</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: eric.deutsch@gustaveroussy.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Bazire, L" sort="Bazire, L" uniqKey="Bazire L" first="L" last="Bazire">L. Bazire</name><affiliation wicri:level="3"><nlm:affiliation>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">La Garenne-Colombes</settlement></placeName></affiliation></author><author><name sortKey="Mazeron, J J" sort="Mazeron, J J" uniqKey="Mazeron J" first="J-J" last="Mazeron">J-J Mazeron</name><affiliation wicri:level="3"><nlm:affiliation>Centre Antoine-Béclère, 47, rue de la Colonie, 75013 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre Antoine-Béclère, 47, rue de la Colonie, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Chargari, C" sort="Chargari, C" uniqKey="Chargari C" first="C" last="Chargari">C. Chargari</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Service de santé des armées, école du Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France; Institut de recherche biomédicale des armées, D19, 91220 Bretigny-sur-Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Service de santé des armées, école du Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France; Institut de recherche biomédicale des armées, D19, 91220 Bretigny-sur-Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Bretigny-sur-Orge</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32389579</idno><idno type="pmid">32389579</idno><idno type="doi">10.1016/j.canrad.2020.04.003</idno><idno type="pmc">PMC7252150</idno><idno type="wicri:Area/Main/Corpus">001365</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001365</idno><idno type="wicri:Area/Main/Curation">001365</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001365</idno><idno type="wicri:Area/Main/Exploration">001365</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]</title><author><name sortKey="Cosset, J M" sort="Cosset, J M" uniqKey="Cosset J" first="J-M" last="Cosset">J-M Cosset</name><affiliation wicri:level="3"><nlm:affiliation>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">La Garenne-Colombes</settlement></placeName></affiliation></author><author><name sortKey="Deutsch, E" sort="Deutsch, E" uniqKey="Deutsch E" first="É" last="Deutsch">É Deutsch</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: eric.deutsch@gustaveroussy.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Bazire, L" sort="Bazire, L" uniqKey="Bazire L" first="L" last="Bazire">L. Bazire</name><affiliation wicri:level="3"><nlm:affiliation>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">La Garenne-Colombes</settlement></placeName></affiliation></author><author><name sortKey="Mazeron, J J" sort="Mazeron, J J" uniqKey="Mazeron J" first="J-J" last="Mazeron">J-J Mazeron</name><affiliation wicri:level="3"><nlm:affiliation>Centre Antoine-Béclère, 47, rue de la Colonie, 75013 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre Antoine-Béclère, 47, rue de la Colonie, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Chargari, C" sort="Chargari, C" uniqKey="Chargari C" first="C" last="Chargari">C. Chargari</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Service de santé des armées, école du Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France; Institut de recherche biomédicale des armées, D19, 91220 Bretigny-sur-Orge, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Service de santé des armées, école du Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France; Institut de recherche biomédicale des armées, D19, 91220 Bretigny-sur-Orge</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Bretigny-sur-Orge</settlement></placeName></affiliation></author></analytic><series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title><idno type="eISSN">1769-6658</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (radiotherapy)</term><term>Cytokine Release Syndrome (etiology)</term><term>Cytokine Release Syndrome (radiotherapy)</term><term>Humans (MeSH)</term><term>Immunocompromised Host (MeSH)</term><term>Immunosuppression (MeSH)</term><term>Lung (radiation effects)</term><term>Lung Diseases (radiotherapy)</term><term>Lymphocyte Depletion (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (radiotherapy)</term><term>Radiotherapy Dosage (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term><term>Dosimétrie en radiothérapie (MeSH)</term><term>Déplétion lymphocytaire (MeSH)</term><term>Humains (MeSH)</term><term>Immunosuppression thérapeutique (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (radiothérapie)</term><term>Maladies pulmonaires (radiothérapie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (radiothérapie)</term><term>Poumon (effets des radiations)</term><term>Sujet immunodéprimé (MeSH)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Poumon</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cytokine Release Syndrome</term></keywords><keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Lung</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Coronavirus Infections</term><term>Cytokine Release Syndrome</term><term>Lung Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Infections à coronavirus</term><term>Maladies pulmonaires</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Humans</term><term>Immunocompromised Host</term><term>Immunosuppression</term><term>Lymphocyte Depletion</term><term>Pandemics</term><term>Radiotherapy Dosage</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Betacoronavirus</term><term>Dosimétrie en radiothérapie</term><term>Déplétion lymphocytaire</term><term>Humains</term><term>Immunosuppression thérapeutique</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Sujet immunodéprimé</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32389579</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1769-6658</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>06</Month></PubDate></JournalIssue><Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title><ISOAbbreviation>Cancer Radiother</ISOAbbreviation></Journal><ArticleTitle>[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]</ArticleTitle><Pagination><MedlinePgn>179-181</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1278-3218(20)30099-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canrad.2020.04.003</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cosset</LastName><ForeName>J-M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deutsch</LastName><ForeName>É</ForeName><Initials>É</Initials><AffiliationInfo><Affiliation>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: eric.deutsch@gustaveroussy.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazire</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazeron</LastName><ForeName>J-J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Centre Antoine-Béclère, 47, rue de la Colonie, 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chargari</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Service de santé des armées, école du Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France; Institut de recherche biomédicale des armées, D19, 91220 Bretigny-sur-Orge, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><VernacularTitle>Irradiation pulmonaire à faible dose pour l’orage de cytokines du COVID-19 : pourquoi pas ?</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cancer Radiother</MedlineTA><NlmUniqueID>9711272</NlmUniqueID><ISSNLinking>1278-3218</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007165" MajorTopicYN="N">Immunosuppression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="Y">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008212" MajorTopicYN="N">Lymphocyte Depletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32389579</ArticleId><ArticleId IdType="pii">S1278-3218(20)30099-8</ArticleId><ArticleId IdType="doi">10.1016/j.canrad.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7252150</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):250-254</Citation><ArticleIdList><ArticleId IdType="pubmed">32140081</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2018 Mar 1;51(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">29496785</ArticleId></ArticleIdList></Reference><Reference><Citation>Liver Transpl. 2020 Jun;26(6):832-834</Citation><ArticleIdList><ArticleId IdType="pubmed">32196933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 May;79(5):667-668</Citation><ArticleIdList><ArticleId IdType="pubmed">32241793</ArticleId></ArticleIdList></Reference><Reference><Citation>Yale J Biol Med. 2013 Dec 13;86(4):555-70</Citation><ArticleIdList><ArticleId IdType="pubmed">24348219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation><ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 Apr 2;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32247695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Apr 4;395(10230):1111</Citation><ArticleIdList><ArticleId IdType="pubmed">32220278</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiother Oncol. 2020 Apr 6;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32342871</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 Apr 6;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32253759</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiother Oncol. 1987 Jun;9(2):119-29</Citation><ArticleIdList><ArticleId IdType="pubmed">3303160</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 May;46(5):846-848</Citation><ArticleIdList><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Phys. 2017 Oct;44(10):e391-e429</Citation><ArticleIdList><ArticleId IdType="pubmed">28688159</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2020 Mar 17;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32181990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Apr;580(7803):311-312</Citation><ArticleIdList><ArticleId IdType="pubmed">32273618</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunotherapy. 2020 Apr;12(5):269-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32212881</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Biol. 2007 Jun;83(6):357-66</Citation><ArticleIdList><ArticleId IdType="pubmed">17487675</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Bretigny-sur-Orge</li><li>La Garenne-Colombes</li><li>Paris</li><li>Villejuif</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Cosset, J M" sort="Cosset, J M" uniqKey="Cosset J" first="J-M" last="Cosset">J-M Cosset</name></region><name sortKey="Bazire, L" sort="Bazire, L" uniqKey="Bazire L" first="L" last="Bazire">L. Bazire</name><name sortKey="Chargari, C" sort="Chargari, C" uniqKey="Chargari C" first="C" last="Chargari">C. Chargari</name><name sortKey="Deutsch, E" sort="Deutsch, E" uniqKey="Deutsch E" first="É" last="Deutsch">É Deutsch</name><name sortKey="Mazeron, J J" sort="Mazeron, J J" uniqKey="Mazeron J" first="J-J" last="Mazeron">J-J Mazeron</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000147 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000147 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32389579
|texte= [Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?]
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32389579" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |